HANGZHOU TIGERMED CO. H 1 (5HZ1) — Tangible Net Worth Ratio
HANGZHOU TIGERMED CO. H 1 (5HZ1) has a Tangible Net Worth Ratio of 99.0% as of March 2026. This metric is calculated by deducting intangible assets (€254.01 Million) from net assets (€24.56 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore HANGZHOU TIGERMED CO. H 1 equity growth rate to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
HANGZHOU TIGERMED CO. H 1 Tangible Net Worth Ratio (2021–2025)
This chart shows how HANGZHOU TIGERMED CO. H 1's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 99.0%, reflecting net assets of €24.56 Billion with intangible assets of €254.01 Million EUR. For live market cap and overall valuation, see HANGZHOU TIGERMED CO. H 1 (5HZ1) market capitalisation.
Annual Tangible Net Worth Ratio for HANGZHOU TIGERMED CO. H 1 (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for HANGZHOU TIGERMED CO. H 1 from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore HANGZHOU TIGERMED CO. H 1 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 98.9% | €24.26 Billion | €276.31 Million | €28.36 Billion | ▲ +0.3 pp |
| 2024 | 98.6% | €24.06 Billion | €336.88 Million | €28.67 Billion | ▲ +0.1 pp |
| 2023 | 98.5% | €24.45 Billion | €371.13 Million | €29.68 Billion | ▼ 0.0 pp |
| 2022 | 98.5% | €22.68 Billion | €338.12 Million | €27.45 Billion | ▼ -0.3 pp |
| 2021 | 98.8% | €20.61 Billion | €250.64 Million | €23.74 Billion | — |